Christopher Horan Insider Profile
11 Followers
Christopher Horan, Chief Tech Operations Officer at Artiva Biotherapeutics, Inc., holds 283.08K shares in Artiva Biotherapeutics, Inc. (Ticker: ARTV), holds 19.85K shares in Dermira (Ticker: ~DERM), holds 19.85K shares in Journey Medical Corp (Ticker: DERM). Most recently, Christopher Horan Sold ― shares of Artiva Biotherapeutics, Inc. on Sep 04, 2026 for an estimated value of $115.58K.
Christopher Horan Artiva Biotherapeutics, Inc. (ARTV)Chief Tech Operations Officer
Artiva Biotherapeutics, Inc. (ARTV)
Chief Tech Operations Officer
Ranked #69,025 out of 108,921 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-15.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Christopher Horan holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Sep 04, 2026 - Today
Return:0.00%
The most profitable trade made by Christopher Horan
Christopher Horan's Trading History
Artiva Biotherapeutics, Inc.
Sep 04, 2026
Chief Tech Operations Officer
Informative Sell
115.58K
$3.05M
Dermira
―
―
―
$372.17K
Journey Medical Corp
May 21, 2019
Chief Technical Ops Officer
Uninformative Buy
183.17K
$147.88K
List of latest transactions for each holding click on a transaction to see Christopher Horan's performance on stock
You May Also Like
Christopher Horan insider profile FAQ
What is the percentage of profitable transactions made by Christopher Horan?
The percentage of profitable transactions made by Christopher Horan is 0%.
What is the average return per transaction made by Christopher Horan?
The average return per transaction made by Christopher Horan is -15.40%.
What stocks does Christopher Horan hold?
Christopher Horan holds: ARTV, ~DERM, DERM stocks.
What was Christopher Horan’s latest transaction?
Christopher Horan latest transaction was an Informative Sell of $115.58K.
What was Christopher Horan's most profitable transaction?
Christopher Horan’s most profitable transaction was an Informative Sell of ARTV stock on September 4, 2026. The return on the trade was 0.00%.
What is Christopher Horan's role in Artiva Biotherapeutics, Inc.?
Christopher Horan's role in Artiva Biotherapeutics, Inc. is Chief Tech Operations Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.